Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 32 33 34 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Bruker Corp–CovalX: mass spectrometry, 201306– collab ww support to combine CovalX high-mass systems with Bruker autoflex + ultraflex instruments 2013-06-06
M-SPEC (DE)–NONE: investment, 201306–201401 bankruptcy Local Court Mainz 280 IN 123/13 2013-06-06
Thermo Fisher–SEVERAL: investment, 201306 common stock offering $2.53b 25.7m+3.85m shares at $85.5/share 2013-06-05
Bruker Corp–3M: MALDI Imaging, 201306– license excl to technique for performing MS analysis on FFPE tissue 2013-06-04
Bruker Corp–3M: MALDI Imaging, 201609– license expansion excl to technique for performing MS analysis on FFPE tissue for pathology 2013-06-04
Univ Hamburg–Bruker Corp: mass spectrometer, 201306 supply existent MALDI Molecular Imager used by Prof H Schlüter in FFPE prostate cancer study UKE 2013-06-04
Exquiron Biotech–Enamine: chemical compound library, 201306– collab multi-year supply of diverse screening compound library by Enamine 2013-06-03
GSK–MorphoSys: MOR103, 201306– global license for €22.5m upfront + €423m milestones + double-digit royalties 2013-06-03
Entelechon–Eurofins: investment, 201306 acquisition by Eurofins MWG Operon 2013-06-01
GOBI project–Genedata: bioinformatics, 201306–201605 Genedata is project partner supplying Genedata Selector for data analysis 2013-06-01
GOBI project–Germany (govt): grant, 201306–201605 BMBF funding for general optimisation of biogas processes 2013-06-01
NOFUN project–EU (govt): grant, 201306– FP7 funding €6.1m 2013-06-01
PS Biotech–High-Tech Gründerfonds: investment, 201306 seed investment by HTGF 2013-06-01
Merck (DE)–BeiGene: cancer drug, 201305– collab co-developm + commercialisation of BRAF inhibitor BeiGene-283 by Merck Serono 2013-05-31
Okairos–GSK: investment, 201305 acquisition for €250m in cash 2013-05-29
Medigene–Sinphar Pharmaceutical: investment, 201305 acquisition €2.4m with 2.4m new shares €1/share by SynCore resulting in 6% shareholding 2013-05-27
Sinphar Pharmaceutical–Medigene: EndoTAG-1, 201305– collab expansion co-developm + commercialisation globally by SynCore Biotechnology 2013-05-27
SIP Biotech Development–Qiagen: companion diagnostics, 201305– collab establishment of joint venture Qiagen (Suzhou) Translational Medicine Center 2013-05-24
Debiopharm–Cenix BioScience: biomarker discovery, 201305– collab Cenix to use HCS to identify predctive biomarkers for cancer drug candidates 2013-05-23
SuppreMol–SEVERAL: investment, 201305 financing round Series D 2nd closing €9.5m 2013-05-21
AOP Orphan–Élan: investment, 201305– acquisition €533.5m with €157.7m cash + €87.8m ordinary shares + €270m milestones ANNOUNCED 2013-05-20
Effector Therapeutics–Abingworth: investment, 201305 financing round Series A totalling $45m incl investor Abingworth 2013-05-20
Effector Therapeutics–Novartis: investment, 201305 financing round Series A totalling $45m incl investor Novartis Venture Funds 2013-05-20
Effector Therapeutics–SEVERAL: investment, 201305 financing round Series A $45m incl USVP + Abingworth + Novartis VF + SR One + Astellas Venture 2013-05-20
NewBridge Pharmaceuticals–Élan: investment, 201305 acquisition 48% share for $40m with option to acquire remaining stake for $244m by 2015 2013-05-20
Evotec–Harvard Univ: drug discovery, 201305– collab identification + optimisation of small molecule antibacterials 2013-05-16
Steigerwald Arzneimittelwerk–Bayer: investment, 201305–201307 acquisition €na 2013-05-16
BASF–Direvo Industrial Biotechnology: feed enzymes, 201305 collab extension joint developm protease for pig + poultry feed w BASF Animal Nutrition 2013-05-15
Dolosys–High-Tech Gründerfonds: investment, 201305 seed financing from HTGF + m2f Investment Ltd 2013-05-15
Dolosys–m2f Investment: investment, 201305 seed financing from HTGF + m2f Investment Ltd 2013-05-15
Dolosys–SEVERAL: investment, 201305 seed financing from HTGF + m2f Investment Ltd 2013-05-15
Merck (DE)–Quintiles: clinical research services, 201305– supply 5y Quintiles sole-primary provider global clinical developm services for Merck Serono 2013-05-15
TeFuProt project–Germany (govt): grant, 201305– funding €4.5m of total project cost €9m 6y by BMBF via »Innovationsinitiative Industr Biotechnologie« 2013-05-15
Bruker Corp–SCiLS GmbH: SCiLS Lab s/w, 201305– collab excl partnership for use of SCiLS Lab s/w w Bruker MALDI Imaging solutions 2013-05-14
Univ Jena–Bruker Corp: mass spectrometer, 201305 supply Prof v Eggeling existent user of Bruker MALDI Imaging equipment 2013-05-14
Univ Jena–SCiLS GmbH: SCiLS Lab s/w, 201305 supply existent Prof v Eggeling is beta tester of SCiLS Lab s/w using Bruker MALDI Imaging equipment 2013-05-14
Greenovation–Biomeva: alfa-galactosidase, 201305– collab developm + manufacturing + supply agreem using BryoMaster moss expression system 2013-05-06
SIRS-Lab–Analytik Jena: investment, 201305 acquisition €na of all assets of bankrupt SIRS-Lab GmbH 2013-05-06
Structural Genomics Consortium–Boehringer: epigenetics, 201305– collab Boehringer joins SGC as new member 2013-05-06
Roche–Evotec: drug discovery services, 201305–201604 collab extension for 3 years discovery small molecule drugs for Genentech 2013-05-01
Evotec–Harvard Univ: drug discovery, 201304– collab target validation for epigenetics-guided cancer drug discovery Dana-Farber Cancer Institute 2013-04-30
AbClon–Pepperprint: peptide microarrays, 201302– distribution with marketing + sales rights for Pepperprint products in Korea 2013-04-29
Boehringer–Oxford BioTherapeutics: drug target discovery, 201304– collab €na to discover cancer antibody targets using OGAP platform 2013-04-29
Conceptus–Bayer: investment, 201304–201306 acquisition merger cash tender offer $1.1b=€852m $31/share Bayer HealthCare LLC 2013-04-29
Ingenuity Systems–Qiagen: investment, 201304 acquisition for $105m in cash 2013-04-29
Becton Dickinson–Bruker Corp: mass spectrometer, 201304– collab expansion sell + provide techn support for MALDI Biotyper w BD Phoenix + EpiCenter 2013-04-27
Jado–NONE: investment, 201301–201304 bankruptcy Jado Technologies GmbH Local Court Dresden 533 IN 2725/12 2013-04-25
Genticel–LCF Rothschild: investment, 201304 financing round €18.2m incl returning co-investor EdRIP 2013-04-24
Genticel–SEVERAL: investment, 201304 financing round €18.2m led by Wellington Partners incl all current institutional investors 2013-04-24
Genticel–Wellington Partners: investment, 201304 financing round €18.2m incl €4m from lead investor Wellington Partners 2013-04-24
GME Medical Engineering–High-Tech Gründerfonds: investment, 201304 financing round totalling €1m inkl returning investor HTGF 2013-04-24
GME Medical Engineering–SEVERAL: investment, 201304 financing round €1m from BayBG + HTGF + Bayern Kapital + private investors incl Dieter Manstein 2013-04-24
Miltenyi Biotec–Omnicom: public relations, 201304 service existent by Fleishman-Hillard 2013-04-24
Activaero–MC Services: public relations, 201304 service existent for Activaero GmbH 2013-04-23
Analytik Ltd–GeSiM: biochip spotting technology, 201304 distribution existent Analytik Ltd is excl distributor for Nano-Plotter in UK + IRL 2013-04-23
Aotec Instrumentos Cientificos–Danaher: investment, 201304 acquisition 100% by Leica Microsystems + Leica Biosystems of former Brazilian distributor 2013-04-23
Owl Biomedical–Miltenyi Biotec: investment, 201304 acquisition €na 2013-04-23
Personal MedSystems–BPCE: investment, 201304 Series A investment €2.5m by Seventure Partners 2013-04-23
Biocrea–MC Services: public relations, 201304 service existent for Biocrea GmbH 2013-04-22
Curetis–HBM: investment, 201304 financing round Series B totalling €12.5m incl €6m from new + lead investor HBM Partners 2013-04-22
Curetis–SEVERAL: investment, 201304 financing round Series B €12.5m incl €6m from new + lead investor HBM Partners 2013-04-22
Allecra Therapeutics–EMBL: investment, 201304 financing round Series A totalling €15m incl co-investor EMBL Ventures 2013-04-18
Allecra Therapeutics–Forbion: investment, 201304 financing round Series A totalling €15m incl co-lead investor Forbion 2013-04-18
Allecra Therapeutics–LCF Rothschild: investment, 201304 financing round Series A totalling €15m incl co-lead investor EdRIP 2013-04-18
Allecra Therapeutics–Orchid Chemicals: antibiotics, 201304– collab strategic partnership w Orchid Chemicals & Pharmaceuticals Ltd 2013-04-18
Allecra Therapeutics–SEVERAL: investment, 201304 financing round Series A €15m co-led by EdRIP + Forbion 2013-04-18
Bruker Corp–Univ Victoria: MS-based clinical tests, 201304– collab development iMALDI assays with UVic GBC Proteomics Centre 2013-04-18
Life Technologies–Ridom: genomic software tools, 201304– collab product integration offering SeqSphere+ bacterial typing s/w on Ion PGM sequencer 2013-04-18
Boehringer–Galapagos: drug discovery, 201304– supply drug discovery services by Argenta to respiratory target of Boehringer 2013-04-17
Lilly–Siemens: PET tracers, 201304 acquisition €na of 2 tau tangle PET tracers from Siemens Medical Solutions USA Inc 2013-04-17
Rodos BioTarget–High-Tech Gründerfonds: investment, 201304 financing round €2.6m with Enjoy Venture + HTGF + KfW ERP Start Fund + private investors 2013-04-17
Rodos BioTarget–SEVERAL: investment, 201304 financing round €2.6m from Enjoy Venture + HTGF + KfW ERP Start Fund + private investors 2013-04-17
Auris Medical–Sofinnova: investment, 201304 financing round Series C CHF47.1m from Sofinnova Ventures + Sofinnova Partners 2013-04-16
Bayer–Monsanto: plant biotechnology, 201304– cross-license agreements betw Monsanto + Bayer CropScience 2013-04-16
Charles River–Bruker Corp: mass spectrometer, 201304– supply MALDI Biotyper to be sold as part of Axcess System w Accugenix database + s/w 2013-04-15
Life Technologies–Thermo Fisher: investment, 201304–201402 acquisition $13.6b in cash $76.13/share 2013-04-15
Planet Biopharmaceuticals–Bertarelli Group: investment, 201304 acquisition 100% incl wholly-owned sub Antigen Laboratories by Ares Life Sciences 2013-04-15
Biodesix–Bruker Corp: MALDI-TOF mass spectrometry, 201304– collab + supply to support developm of MALDI-MS-based clinical diagnostic tests 2013-04-11
Eyevensys–Boehringer: investment, 201304 2nd financing round incl initial investor Boehringer Ingelheim Venture Fund 2013-04-11
Eyevensys–SEVERAL: investment, 201304– 2nd financing round with initial investor Boehringer Ingelheim Venture Fund 2013-04-11
Monsanto–Dieckmann: seeds, 201304 acquisition €na part of European business incl rape + rye seeds by Monsanto Agrar Deutschland GmbH 2013-04-11
Novaliq–Hopp Group: investment, 201304 financing round €13.9m from Dievini Hopp BioTech Holding GmbH & Co KG 2013-04-11
Panatecs–Waters: chromatography, 201304– distribution sale of Waters chromatography products via Panatecs web shop 2013-04-11
Panatecs–Waters: reagents, 201304– distribution sale of Waters analytical standards + reagents via Panatecs web shop 2013-04-11
ETG GmbH–Analytik Jena: investment, 201304 acquisition further 60% share raising Analytik Jena AG share to 80% 2013-04-10
High-Tech Gründerfonds–Lanxess: investment, 201304 investment of low 7-digit figure in High-Tech Gründerfonds II 2013-04-10
Univ Tokyo–CovalX: mass spectrometry, 201304 supply HM3 system mounted onto Axima Performance MALDI-TOF at Lab of T Kawamura 2013-04-10
CLC bio–IBM: bioinformatics, 201304 collab product integration of IBM hardware + CLC Genomics Server s/w + Workbench s/w for sequencing analytics 2013-04-09
Priaxon–Proteros: drug discovery, 201304– collab lead discovery small molecular modulators of protein-protein interaction targets 2013-04-09
Canbex Therapeutics–Merck (DE): investment, 201304 financing round totalling £2.1m incl lead investor Merck Serono Ventures 2013-04-08
Canbex Therapeutics–SEVERAL: investment, 201304 financing round £2.1m led by Merck Serono Ventures 2013-04-08
Sophia Genetics–SEVERAL: investment, 201304 financing round Series A CHF2.8m from private investors 2013-04-08
Terrain Consulting–Conway Data: investment, 201304 acquisition of Terrain Consulting Services GmbH by CDI 2013-04-08
AstraZeneca–Bayer: drug discovery, 201304– collab extension 3y mutual access to compound libraries + screening techn for selected projects 2013-04-03
Merck (DE)–BioMed X: pharma research, 201304– collab Merck Serono is 1st partner of new research project-focussed incubator concept at BioMed X 2013-04-03
UVP–Analytik Jena: investment, 201304 acquisition €na 100% of UVP LLC + wholly-owned sub Ultra-Violet Products Ltd 2013-04-02
AMR Inc–CovalX: mass spectrometry, 201304– collab distribution in Japan by AMR Inc 2013-04-01
Bio Base NWE project–EU (govt): grant, 201304– €6.2m project 50% funded by ERPD Interreg IVB North West Europe Programme 2013-04-01
CellnTec–Biognosys: MRM technology, 201304– collab offering of MRM proteomic analysis as part of skin testing services of CellnTec 2013-04-01
GeneWake–Germany (govt): grant, 201304– 2-year BMBF grant €200k to develop pharmacodx test for prostate + bladder cancer within m4 Initiative 2013-04-01
next pagenext page 1 2 3 ... 32 33 34 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top